DEF 14A: CNO Financial Group Files Definitive Proxy Statement for 2024 Annual Meeting

Sentiment:

Definitive Proxy Statement


CNO Financial Group's proxy statement outlines proposals for the upcoming annual shareholder meeting, including director elections, executive compensation, and shareholder rights plan.

Summary

  • CNO Financial Group has filed a definitive proxy statement regarding its 2024 annual meeting of shareholders.
  • The meeting will be held virtually on May 9, 2024.
  • Shareholders of record as of March 11, 2024, are entitled to vote.
  • The proposals include the election of eight directors, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as the independent auditor, and approval of the Amended and Restated Section 382 Shareholder Rights Plan.
  • The Board of Directors unanimously recommends voting FOR all director nominees and in favor of approving Proposals 2, 3, and 4.
  • In 2023, CNO Financial Group generated $311 million in free cash flow and returned $233 million to shareholders through share repurchases and dividends.
  • As of December 31, 2023, the company had $521.8 million remaining under its share repurchase authorization.
  • The company's consolidated risk-based capital ratio was 402% at the end of 2023.
  • Book value per diluted share, excluding accumulated other comprehensive income (loss), increased to $33.94 at the end of 2023 from $31.89 at the end of 2022.
  • The debt to total capital ratio at the end of 2023, excluding accumulated other comprehensive income (loss), was 23.1%.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting solid financial results and strategic initiatives. However, it also acknowledges some challenges, such as expense-related headwinds and a decrease in net income, resulting in a moderately positive sentiment score.

Positives

  • CNO Financial Group delivered solid 2023 financial results.
  • The company increased agent counts every quarter and reported record growth across multiple product categories within the Consumer Division.
  • Client assets in brokerage and advisory were up 20% year-over-year to a record $3.2 billion.
  • Demand for Worksite products exceeded pre-pandemic levels, with life and health insurance NAP up 29% in the Division.
  • Producing agent count grew every quarter of 2023 across both divisions, with the Consumer Division up 9% and the Worksite Division up 27%.
  • The company enhanced its capital efficiency by establishing a Bermuda affiliate, CNO Bermuda Re, and executed its first reinsurance transaction.
  • Fitch upgraded CNO's Insurer Financial Strength (IFS) rating to A.

Negatives

  • Net income decreased to $276.5 million in 2023 from $630.6 million in 2022, reflecting non-economic market impacts.
  • The insurance industry faced significant expense-related headwinds in 2023 from higher inflation and regulatory administration.

Risks

  • The company faces risks related to economic conditions, regulatory changes, and competition within the insurance and financial services industries.
  • Cybersecurity and data privacy risks are ongoing concerns.
  • The company's ability to effectively manage its capital and liquidity is crucial for maintaining financial stability.
  • The company's ability to utilize Tax Benefits to offset taxable income can be further limited in certain circumstances.

Future Outlook

The company's full-year performance underscores the health and strength of its business model and lays the foundation for sustained profitable growth.

Management Comments

  • Throughout 2023, our focus remained squarely on delivering growth and executing our strategic priorities.
  • We view the financial results of our business based on our consolidated product line segments (annuity, health and life) and the investment and fee income segments.
  • Further integrating our unique set of capabilities will get us deeper into the employer/employee value chain and strengthen our position to capture future growth.

Industry Context

CNO Financial Group operates in the insurance and financial services industry, competing with other Fortune 1000 companies. The company's focus on the middle-income market and its diverse distribution channels differentiate it from some competitors.

Comparison to Industry Standards

  • The document mentions CNO Financial Group's performance relative to the S&P Life & Health Insurance Index and the S&P MidCap 400 Index.
  • CNO Financial Group's stock outperformed both indices over the 5-year period ended December 31, 2023.
  • The company also compares its executive compensation practices to a select group of peer companies, including American Equity Investment Life Holding Co., Lincoln National Corporation, and Voya Financial, Inc.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorStephen N. DavidNAMay 9, 2024Retirement

Related Party Transactions

  • There were no such transactions or agreements involving the Company and a Related Person in 2023 or to date in 2024.

Stakeholder Impact

  • The company's performance and strategic initiatives impact shareholders, employees, customers, and communities.
  • The company's commitment to corporate social responsibility aims to create value for all stakeholders.

Next Steps

  • Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will hold its annual meeting on May 9, 2024.
  • The Board and management will consider the results of the advisory vote on executive compensation.

Key Dates

DateDescription
January 20, 2009Date of the original Section 382 Rights Agreement.
January 30, 2009Record date for the dividend of preferred share purchase rights.
March 11, 2024Record date for the 2024 Annual Meeting of Shareholders.
March 27, 2024Approximate date of mailing the Notice of Internet Availability of Proxy Materials.
May 8, 2024Deadline for submitting votes by internet, telephone or mail.
May 9, 2024Date of the 2024 Annual Meeting of Shareholders.
November 27, 2024Deadline for receiving shareholder proposals for the 2025 Annual Meeting.
January 9, 2025Earliest date for receiving non-proxy access director nomination or shareholder proposal for the 2025 Annual Meeting.
February 8, 2025Latest date for receiving non-proxy access director nomination or shareholder proposal for the 2025 Annual Meeting.

Keywords

proxy statement, annual meeting, directors, executive compensation, shareholder rights plan, financial results, risk management, corporate governance, CNO Financial Group, insurance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.